Thalassemia Patients and Friends
Discussion Forums => Working Towards a Cure => Topic started by: Mukta on September 17, 2015, 02:39:52 PM
-
Friends ,
Found a article in today's Hindustan times on a possible medicine in future for Thalassaemia by Sanofi
Does anyone know anything more on this ??
The link to this article is the following :
http://www.hindustantimes.com/business-news/india-may-receive-first-ever-thalassaemia-medicine/article1-1390883.aspx
-
Thank Mukta. Its good. Hope for the best...
-
The company plans to study the effect of drug depending on the intensity of disease — from major to intermediate to minor.
Great!
-
If anyone can find the name of the drug, I would appreciate it.
-
Andy,
when I researched in google, I found that Sanofi-Genzyme has invested in Bluebird bio and it shows up in their bioventure portfolio. Bluebird bio is MA based. So I am wondering if this is what they are referring to in the article.
http://sanofigenzymebioventures.com/portfolio/portfolio-companies.html
-
I think this is the one the article was talking about: LentiGlobin BB305 by Sanofi
http://www.zacks.com/stock/news/178498/bluebird-bio-reports-encouraging-data-on-thalassemia-drug
-
Thanks Mukta for the information.
Waiting for the day when all of our child's will get remedy from transfusion... :heartpink :heartpink
-
But lentiglobin doesn't belong to sanofi but to bluebird :huh